Instead, glioma-secreted factors such as granulocyte–macrophage colony-stimulating factor (GM-CSF) and interferon-gamma (IFN-γ) sustained TAM viability despite CSF-1R blockade. This evidence concerns the gene CSF1R and central nervous system cancer.